Journals
Publish with us
Publishing partnerships
About us
Blog
Oxidative Medicine and Cellular Longevity
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Oxidative Medicine and Cellular Longevity
/
2021
/
Article
/
Tab 2
/
Research Article
Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy
Table 2
The presence of comorbidities in the study population.
Comorbidities,
(%)
Total (
)
ICU patients
Live (
)
Dead (
)
Hypertension
109 (69.4)
40 (62.5)
69 (74.2)
0.158
Diabetes
52 (33.1)
26 (40.6)
26 (28.0)
0.121
Obesity
14 (8.9)
6 (9.5)
8 (8.5)
1.000
HOBP
8 (5.1)
1 (1.6)
7 (7.5)
0.095
Asthma
6 (3.8)
2 (3.1)
4 (4.3)
0.706
Coronary disease
28 (17.8)
10 (15.6)
18 (19.4)
0.672
Cardiomyopathy
14 (8.9)
6 (9.4)
8 (8.6)
1.000
Number of comorbidities
None
37 (23.7%)
18 (28.6%)
19 (20.4%)
0.457
1
48 (30.8%)
17 (27.0%)
31 (33.3%)
≥2
71 (45.5%)
28 (44.4%)
43 (46.2%)
Total number of patients with comorbidities
120 (76.4%)
46 (71.9%)
74 (79.6%)
0.339